HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altaf Mohammed Selected Research

hydroxide ion

1/2020Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Altaf Mohammed Research Topics

Disease

41Neoplasms (Cancer)
12/2021 - 01/2008
18Carcinogenesis
08/2017 - 01/2010
16Pancreatic Neoplasms (Pancreatic Cancer)
10/2019 - 01/2008
14Adenocarcinoma
11/2021 - 09/2012
11Colonic Neoplasms (Colon Cancer)
11/2021 - 01/2008
8Carcinoma (Carcinomatosis)
11/2021 - 11/2010
8Inflammation (Inflammations)
01/2021 - 12/2011
8Carcinoma in Situ
11/2017 - 11/2010
7Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 12/2012
7Adenoma (Adenomas)
11/2021 - 09/2013
7Polyps
01/2021 - 12/2011
4Lung Neoplasms (Lung Cancer)
01/2021 - 09/2013
4Adenocarcinoma of Lung
01/2021 - 09/2013
4Transitional Cell Carcinoma
01/2016 - 08/2013
4Intestinal Polyps
03/2014 - 02/2012
4Aberrant Crypt Foci
01/2014 - 01/2008
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 08/2013
3Body Weight (Weight, Body)
01/2014 - 01/2008
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2021 - 03/2014
2Hepatocellular Carcinoma (Hepatoma)
11/2020 - 01/2016
2Fibrosis (Cirrhosis)
11/2020 - 04/2015
1Adenomatous Polyps
01/2021
1Intestinal Neoplasms (Intestinal Cancer)
01/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
11/2020
1Precancerous Conditions
11/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2019

Drug/Important Bio-Agent (IBA)

12Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2021 - 12/2011
10Pharmaceutical PreparationsIBA
01/2020 - 12/2013
9AzoxymethaneIBA
11/2021 - 01/2008
7Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2013
7licofeloneIBA
08/2018 - 12/2011
6Cyclin D1IBA
01/2021 - 02/2012
5EnzymesIBA
03/2017 - 12/2011
4CytokinesIBA
01/2021 - 12/2011
4Naproxen (Naprosyn)FDA LinkGeneric
01/2021 - 08/2018
4PolyaminesIBA
11/2016 - 12/2014
4Gefitinib (Iressa)FDA Link
01/2016 - 11/2010
4CP 31398IBA
01/2015 - 05/2012
3VaccinesIBA
12/2021 - 01/2018
3CarcinogensIBA
11/2021 - 09/2013
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 01/2016
3Caspase 3 (Caspase-3)IBA
11/2019 - 05/2013
3MicroRNAs (MicroRNA)IBA
04/2019 - 03/2011
3Eflornithine (Ornidyl)FDA Link
11/2016 - 05/2013
3Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
10/2015 - 12/2011
3CateninsIBA
10/2015 - 05/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2014 - 08/2013
3Lipoxygenase (Lipoxygenase-1)IBA
07/2014 - 12/2011
2AcidsIBA
11/2021 - 01/2014
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2021 - 01/2020
2Sulindac (Copal)FDA LinkGeneric
01/2021 - 08/2018
2Neoplasm Antigens (Tumor Antigens)IBA
11/2020 - 01/2018
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2020 - 12/2013
2Metformin (Glucophage)FDA LinkGeneric
01/2020 - 12/2013
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2019 - 08/2018
2Celecoxib (Celebrex)FDA Link
08/2018 - 12/2011
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
08/2018 - 07/2014
2DNA (Deoxyribonucleic Acid)IBA
08/2017 - 05/2012
2Biological ProductsIBA
08/2017 - 04/2015
2MucinsIBA
03/2017 - 01/2016
2N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase)IBA
03/2017 - 01/2016
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2016 - 10/2012
2Sirolimus (Rapamycin)FDA Link
01/2016 - 12/2015
2TOR Serine-Threonine KinasesIBA
12/2015 - 12/2013
24- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
12/2015 - 09/2013
2ErbB Receptors (EGF Receptor)IBA
10/2015 - 11/2010
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2015 - 02/2012
2Raloxifene Hydrochloride (Evista)FDA Link
03/2014 - 12/2013
2Estrogen ReceptorsIBA
03/2014 - 12/2013
2Estrogens (Estrogen)FDA Link
03/2014 - 12/2013
2Bexarotene (LGD1069)FDA Link
12/2013 - 02/2012
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2013 - 01/2008
2Atorvastatin (Lipitor)FDA Link
05/2013 - 10/2012
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
12/2012 - 01/2008
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
12/2012 - 12/2011
2Transcription Factors (Transcription Factor)IBA
05/2012 - 03/2011
1Immunomodulating AgentsIBA
12/2021
1Interleukin-6 (Interleukin 6)IBA
11/2021
1Proton Pump InhibitorsIBA
11/2021
1Omeprazole (Prilosec)FDA LinkGeneric
11/2021
1Matrix Metalloproteinase 7 (Matrilysin)IBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1Cancer VaccinesIBA
11/2020
1Immune Checkpoint InhibitorsIBA
11/2020
1Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2020
1hydroxide ionIBA
01/2020
1Drug CombinationsIBA
01/2020
1Diphosphonates (Bisphosphonates)IBA
01/2020
1Zoledronic Acid (Zometa)FDA Link
01/2020
1Dinoprostone (PGE2)FDA Link
11/2019
1Tumor Biomarkers (Tumor Markers)IBA
11/2019
1GastrinsIBA
10/2019
1Cholecystokinin B ReceptorIBA
10/2019
1YF 476IBA
10/2019
14- bromo- N- (1- (2,4- difluoro- phenyl)ethyl)- 2- (quinoxaline- 5- sulfonylamino)benzamideIBA
10/2019
1GlucocorticoidsIBA
04/2019

Therapy/Procedure

16Chemoprevention
03/2021 - 01/2008
2Therapeutics
11/2020 - 01/2014
1Colectomy
01/2021
1Immunotherapy
11/2020